Skip to content

A First-In-Human Trial of the novel T cell Immunotherapy pTTL in Patients with Advanced Colorectal Cancer

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512296-13-00
Acronym
NEOGAP-CRC-01
Enrollment
16
Registered
2024-09-05
Start date
2023-04-03
Completion date
Unknown
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Sponsors

NEOGAP Therapeutics AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 19, 2026